EndyMed gets FDA approval for radio frequency anti-aging treatment

By Simon Pitman

- Last updated on GMT

EndyMed Medical says it has received FDA clearance for its non-invasive anti-wrinkle and rhytide treatment, Pro, the first of its kind to get approval in the US.

The technology is the third generation 3Deep radio frequency technology, based on multiple, phase controlled sources and has been approved for use by medical practitioners and beauty professionals.

The equipment can be used to control the power, depth and 3-dimensional pattern of radio frequency energy delivered to the skin, resulting in a targeted, effective treatment that the company says is personalized, safe and totally painless.

FDA approval establishes the treatment

“FDA clearance establishes our company as a significant player in the worldwide aesthetics market,”​ said Uzi Blumensohn, EndyMed CEO.

“Our 3Deep technology platform is proven to be highly effective in the treatment of facial wrinkles and importantly, has long-lasting effects, an important benefit for both physicians and their patients.”

Clinical studies have shown that the technology showed positive effects on the reduction of wrinkles in more than 80 percent of patients, three months after the end of the treatment.

Tapping into growth in non-invasive treatments

In line with radio frequency treatments, laser treatments have also become a popular means of treating both wrinkles and acne, particularly in the European and US markets.

The latest development in that particular market is the rise of hand-held technologies that can be administered in the home.

Companies marketing these kind of technologies include a partnership between Cynosure and Unilever and Palomar Medical Technologies.

During 2008 the number of non-invasive medical procedures carried out in the US rose by 5 percent to 10.4 million, according to figures from American Society of Plastic Surgeons.

Related topics: Market Trends

Related news

Follow us

Products

View more

Webinars